Back to User profile » Dr Heng Xu

Papers published by Dr Heng Xu:


Lower Serum Matrix Metalloproteinase‑9 in Metastatic Patients with Esophageal Squamous Cell Carcinoma After Concurrent Radiotherapy Was Significant for Prognosis

Ye Z, Zhao H, Zhou W, Ye T, Geng C, Li X, Yuan L, Du M, Xu H, Wang Q

OncoTargets and Therapy 2020, 13:12857-12866

Published Date: 15 December 2020

Relevance of EGFR Between Serum VEGF and MMP-9 in Primary Hepatocellular Carcinoma Patients with Transarterial Chemoembolization

Cao S, Zhu S, Yin W, Xu H, Wu J, Wang Q

OncoTargets and Therapy 2020, 13:9407-9417

Published Date: 23 September 2020

Serum Platelet-Derived Growth Factor Is Significantly Lower in Patients with Lung Cancer and Continued to Decrease After Platinum-Based Chemotherapy

Ma R, Yang Q, Cao S, Liu S, Cao H, Xu H, Wu J, Feng J

OncoTargets and Therapy 2020, 13:1883-1892

Published Date: 4 March 2020

Monoclonal antibody AC10364 inhibits cell proliferation in 5-fluorouracil resistant hepatocellular carcinoma via apoptotic pathways

Wu J, Qu J, Cao H, Jing C, Wang Z, Xu H, Ma R

OncoTargets and Therapy 2019, 12:5053-5067

Published Date: 28 June 2019